Id
Protein
PTM type
Site
Species
Disease
Celline
Drug
Regulatory
Score
Ref.
acc00001 Tubulin alpha chain-like 3 oxidation Met320 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00002 Tubulin alpha-1B chain oxidation Met313 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00003 Detyrosinated tubulin alpha-1B chain oxidation Met313 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00004 Tubulin alpha-4A chain oxidation Met313 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00005 Myosin regulatory light chain 12A oxidation Met24 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00006 Myosin regulatory light chain 12B oxidation Met25 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00007 Myosin regulatory light polypeptide 9 oxidation Met25 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00008 Histone H2B type 1-M oxidation Met63 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00009 Histone H2B type 1-N oxidation Met63 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00010 Histone H2B type 1-H oxidation Met63 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00011 Histone H2B type 2-F oxidation Met63 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00012 Histone H2B type 1-C/E/F/G/I oxidation Met63 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00013 Histone H2B type 1-D oxidation Met63 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00014 Histone H2B type 1-K oxidation Met63 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00015 Histone H2B type 1-L oxidation Met63 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00016 Histone H2B type F-S oxidation Met63 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00017 Histone H2B type 2-E oxidation Met63 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00018 Histone H2B type 1-B oxidation Met63 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00019 Histone H2B type 1-O oxidation Met63 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00020 Histone H2B type 1-J oxidation Met63 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00021 Histone H2B type 3-B oxidation Met63 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00022 Filamin-B oxidation Met491 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00023 Annexin A1 oxidation Met318 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00024 Glyceraldehyde-3-phosphate dehydrogenase oxidation Met105 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00025 "Keratin, type I cytoskeletal 18" oxidation Met402 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00026 Alpha-enolase oxidation Met94 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00027 Annexin A2 oxidation Met240 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00028 Putative annexin A2-like protein oxidation Met240 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00029 Heat shock protein HSP 90-beta oxidation Met602 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00030 Vimentin oxidation Met347 human Breast cancer MDA-MB-231 SU212 Negative 5.0 PXD018929
acc00031 Small ribosomal subunit protein eS17 oxidation Met126 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00032 Inosine-5'-monophosphate dehydrogenase 2 oxidation Met179 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00033 Elongation factor 2 oxidation Met741 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00034 Elongation factor 2 oxidation Met533 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00035 Pyruvate kinase PKM oxidation Met239 human Breast cancer MDA-MB-231 SU212 Negative 5.0 PXD018929
acc00036 Small ribosomal subunit protein uS3 oxidation Met157 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00037 14-3-3 protein theta oxidation Met160 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00038 14-3-3 protein beta/alpha oxidation Met162 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00039 "14-3-3 protein beta/alpha, N-terminally processed" oxidation Met160 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00040 Calreticulin oxidation Met122 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00041 Transketolase oxidation Met266 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00042 Elongation factor 1-delta oxidation Met211 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00043 Protein S100-A11 oxidation Met43 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00044 Myosin-9 oxidation Met879 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00045 Myosin-9 oxidation Met1190 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00046 Eukaryotic initiation factor 4A-III oxidation Met7 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00047 Transitional endoplasmic reticulum ATPase oxidation Met550 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00048 Myosin light polypeptide 6 oxidation Met73 human Breast cancer MDA-MB-231 SU212 Positive 5.0 PXD018929
acc00049 "Actin, cytoplasmic 1" oxidation Met47 human Breast cancer MDA-MB-231 SU212 Negative 5.0 PXD018929
acc00050 "Actin, cytoplasmic 1, N-terminally processed" oxidation Met47 human Breast cancer MDA-MB-231 SU212 Negative 5.0 PXD018929